|
KMID : 1161420220250111011
|
|
Journal of Medicinal Food
2022 Volume.25 No. 11 p.1011 ~ p.1020
|
|
|
Therapeutic Effect of Fucoidan on Metabolic Diseases: Experimental Data and Clinical Evidence
|
|
Villar Miriam Mendez-del
Perez-Rubio Karina G.
Hernandez-Corona Diana M.
Cortez-Navarrete Marisol
|
|
|
Abstract
|
|
|
|
The rising prevalence of metabolic diseases represents a major challenge to public health worldwide. Therefore, there is a strong need to conduct research on the effectiveness of complementary and alternative therapies for metabolic disorders. Fucoidan is a fucose-enriched and sulfated polysaccharide extracted from ubiquitous brown seaweed. The antihypertensive, antidiabetic, antiobesity, and hypolipidemic effects of fucoidan have been reported in preclinical research and clinical trials. This study aims to review the mechanisms of action and the experimental and clinical use of different types of fucoidan for the treatment of metabolic diseases.
|
|
|
KEYWORD
|
|
|
dyslipidemia, fucoidan, hypertension, obesity, type 2 diabetes mellitus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
 
|